Minnesota’s PDAB can cap drug reimbursement rates, but critics argue UPLs risk disrupting access to HIV medications and undermining ADAP/340B-funded services. Patients urge meaningful engagement so affordability doesn’t come at the cost of availability.
Prescription Drug Affordability Board
Posted inOpinion
State’s new prescription drugs plan may come up short
Minnesota established the Prescription Drug Affordability Board (PDAB) to negotiate drug prices to manage patient prescription costs,